Swipe om te navigeren naar een ander artikel
To assess the impact of diabetes on quality of life (QoL) and identify major determinants affecting that impact using a multiple regression model.
This was a cross-sectional design. The audit of diabetes-dependent quality of life (ADDQoL) was administered to assess QoL.
A sample of 256 outpatients with type 2 diabetes was recruited. A negative impact of diabetes was observed on all life domains. The first three most impacted life domains were ‘future’, ‘freedom to eat’, and ‘self-confidence’. ‘Freedom to eat’ was also the domain the most frequently impacted in five previous ADDQoL studies conducted in Singapore, UK, India, the United States, and Slovakia. Factors negatively associated with some domain scores were younger age (future), being male (close personal relationship and sex life), more education (leisure activities, future, dependence, and freedom to drink), low income (leisure activities), having more diabetic complications (do physically and sex life), treatment with insulin (finances and living conditions), and higher HbA1c (freedom to drink).
QoL is impaired in patients with diabetes, especially for the ‘freedom to eat’ domain, indicating that an intervention to improve dietary freedom might be a good way of improving QoL. Greater negative impact of diabetes on QoL was associated with being younger, male, more educated with low income, more diabetes complications, higher HbA1c, and using insulin. These need to be considered in responding to patients’ individual needs.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Bradley, C. (2001). Importance of differentiating health status from quality of life. The Lancet, 357, 7–8. CrossRef
Rubin, R., & Peyrot, M. (1999). Quality of life and diabetes. Diabetes Metabolism Research and Review, 15(3), 205–218. CrossRef
Bradley, C., & Speight, J. (2002). Patient perceptions of diabetes and diabetes therapy: Assessing quality of life. Diabetes/Metabolism Reviews, 18(S3), S64–S69.
The DAFNE Study Group. (2002). Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: Dose adjustment for normal eating (DAFNE) randomised controlled trial. British Medical Journal, 325(7367), 746–749. CrossRef
Ashwell, S. G., Bradley, C., Stephens, J. W., Witthaus, E., & Home, P. D. (2008). Treatment satisfaction and quality of life with insulin glargine plus insulin lispro compared with NPH insulin plus unmodified human insulin in individuals with type 1 diabetes. Diabetes Care, 31(6), 1112–1117. PubMedCrossRef
American Diabetes Association. (2010). Standards of medical care in diabetes—2010. Diabetes Care, 33(Supplement 1), S11–S61. CrossRef
Singh, H., & Bradley, C. (2006). Quality of life in diabetes. International Journal of Diabetes in Developing Country, 26(1), 7–10. CrossRef
Luscombe, F. A. (2002). Health-related quality of life measurement in type 2 diabetes. Value in Health, 3(Suppl. 1), S15–S28.
Pala, T., Eser, E., Özmen, B., Aydemir, Ö., & Boyvoda, S. (2004). The determinants of quality of life including treatment satisfaction in patients with type two diabetes mellitus: Are different generic Qol instruments sensitive to the same determinants? Turkish Journal of Endocrinology and Metabolism, 3, 91–99.
- The quality of life of adults with type 2 diabetes in a hospital care clinic in Taiwan
Mei Chang Yeh
- Springer Netherlands